Benitec Biopharma (BNTC) EBT Margin Growth (1y) (2020 - 2023)

Benitec Biopharma (BNTC) EBT Margin Growth (1y) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1,526.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -683.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 813.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Benitec Biopharma 530.96 Mn 530.96 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 -331,852.00
Dec 31, 2022 -2.53 Mn
Mar 31, 2022 37.26 Mn
Dec 31, 2021 33.83 Mn
Jun 30, 2021 -24.86 Mn
Mar 31, 2021 -37.26 Mn
Dec 31, 2020 -35.55 Mn
Sep 30, 2020 -138,667.00